> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Merck BLA for C. Difficile
- URL: https://www.fdaweb.com/panel-to-discuss-merck-bla-for-c-difficile/
- Published: 2016-04-15T12:00:00.000Z
- Updated: 2026-09-14T20:55:07.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135389

*Federal Register* Notice: FDA’s Antimicrobial Drugs Advisory Committee will meet 6/9, from 8:30 a.m. to 5 p.m. at FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. The committee will discuss a Merck BLA for bezlotoxumab (MK-6072) injection for the proposed indication of preventing *Clostridium difficile* infection recurrence. Contact **Lauren D. Tesh**, (301) 796-9001\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-04-15/pdf/2016-08637.pdf?ref=fdaweb.com)